PharmaNet Development Group Inc (CIK: 0001089542) EDGAR, Information, Filings... CompaniesBIO.Com

PharmaNet Development Group Inc

Mailing address
504 CARNEGIE CENTER, PRINCETON, Delaware, 08540-6242
Phone
609-951-6800
State location
New Jersey
State of incorporation
Delaware
Fiscal year end
December 31
SIC
8731 - (CF Office: Office of Trade & Services) SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Filings
N/A

PharmaNet Development Group Inc (CIK: 0001089542) is an American company incorporated in the state of New Jersey. Head office is located at 504 CARNEGIE CENTER, PRINCETON, New Jersey, 08540-6242. Work in the industry 8731 - (CF Office: Office of Trade & Services) SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH. PharmaNet Development Group Inc is a public company and trade via Over-The-Counter (OTC).

Old names:

SFBC INTERNATIONAL INC from 1999-20-Aug to 2006-14-Aug

Owner	Filings	Transaction Date	Type of Owner
LEVY PAUL S	0001110176	Mar-20-2009	director, 10 percent owner
FRANK RAMSEY A	0001284108	Mar-20-2009	director, 10 percent owner
JLL Associates G.P. VI, L.L.C.	0001459121	Mar-20-2009	10 percent owner
JLL Associates VI, L.P.	0001459122	Mar-20-2009	10 percent owner
JLL Partners Fund VI, L.P.	0001459123	Mar-20-2009	10 percent owner
PDGI Holdco, Inc.	0001460256	Mar-20-2009	10 percent owner
Strothman Peter M	0001460258	Mar-20-2009	director, 10 percent owner
Taylor Thomas S	0001460259	Mar-20-2009	director, 10 percent owner
JLL PharmaNet Holdings, LLC	0001460310	Mar-20-2009	10 percent owner
Sheldrick Robin Cashen	0001425730	Feb-01-2008	officer: Senior VP, Human Resources
Di Ianni Mark	0001383409	Dec-04-2006	officer: See Remarks
WOLD OLSEN PER	0001181185	Nov-27-2006	director
OLIVIER DAVID M	0001231486	Nov-27-2006	director
TOMBROS PETER G	0001007933	Oct-19-2006	director
CLASSON ROLF A	0001030325	Oct-19-2006	director
Hamill John P	0001349581	Aug-24-2006	officer: EVP, CFO, Scty. and Treas.
Newman Thomas Joseph	0001373721	Aug-24-2006	officer: EVP, Late Stage Development
Boucher-Champagne Johane	0001362316	Apr-28-2006	officer: Exec VP of Early Clinical Dev.
LUCKING DAVID	0001253111	Jul-01-2005	director
Golieb Arnold	0001330940	Jun-21-2005	director
Elias Lewis R	0001331315	Jun-21-2005	director
McMullen Jeffrey P	0001311647	Dec-22-2004	officer: Pres & CEO of Subsidiary
LEVINE JACK	0001124852	Dec-02-2003	director
ADAMS MICHAEL P	0001189120	Nov-05-2003	officer: CEO of Subsidiary
INGENITO GARY	0001279473	Oct-15-2003	officer: Senior Vice President
NATAN DAVID	0001253108	Aug-18-2003	officer: VP-Finance (CFO)
CASANAS RAMIRO	0001135243	Aug-11-2003	officer: Chief Accounting Officer
LEBEL MARC	0001253074	Jul-14-2003	officer: President of Subsidiary
DR WEINSTEIN LEONARD L	0001124851	Jun-13-2003	director
HANTMAN ARNOLD	0001124884	Jun-13-2003	director, officer: Chief Executive Officer
KRINSKY LISA MD	0001124850	Jun-12-2003	director, 10 percent owner, officer: President, Chairman of Board
HOLMES DR GREGORY B	0001124883	Jun-12-2003	officer: Executive Vice President

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by PharmaNet Development Group Inc

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000914208-10-000121 (34 Act) Size: KB	Feb-12-2010	005-61063 10596519
NO ACT	Document	Acc-no: 9999999997-09-019585 (34 Act) Size: KB	May-08-2009	001-16119 09011604
NO ACT	Document	Acc-no: 9999999997-09-019584 (34 Act) Size: KB	May-08-2009	001-16119 09011603
NO ACT	Document	Acc-no: 9999999997-09-019583 (34 Act) Size: KB	May-08-2009	001-16119 09011602
15-12B	Document	Notice of termination of registration of a class of securities under Section 12(b) Acc-no: 0001341004-09-000939 (34 Act) Size: KB	May-08-2009	001-16119 09808810
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001140361-09-009338 (34 Act) Size: KB	Apr-09-2009	005-61063 09742909
8-K	Document	Current report filing Acc-no: 0001341004-09-000702 (34 Act) Size: KB	Apr-02-2009	001-16119 09725629
EFFECT	Document	Acc-no: 9999999995-09-000818 (33 Act) Size: KB	Apr-01-2009	333-69112 09725114
EFFECT	Document	Acc-no: 9999999995-09-000802 (33 Act) Size: KB	Apr-01-2009	333-122634 09725112
EFFECT	Document	Acc-no: 9999999995-09-000806 (33 Act) Size: KB	Apr-01-2009	333-145317 09725109
EFFECT	Document	Acc-no: 9999999995-09-000801 (33 Act) Size: KB	Apr-01-2009	333-120152 09725103
EFFECT	Document	Acc-no: 9999999995-09-000798 (33 Act) Size: KB	Apr-01-2009	333-109098 09725101
25-NSE	Document	Acc-no: 0001354457-09-000083 (34 Act) Size: KB	Mar-31-2009	000-31273
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001341004-09-000662 (33 Act) Size: KB	Mar-31-2009	333-69112 09715774
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001341004-09-000661 (33 Act) Size: KB	Mar-31-2009	333-120152 09715772
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001341004-09-000660 (33 Act) Size: KB	Mar-31-2009	333-109098 09715769
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001341004-09-000659 (33 Act) Size: KB	Mar-31-2009	333-122634 09715768
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001341004-09-000658 (33 Act) Size: KB	Mar-31-2009	333-145317 09715765
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001341004-09-000657 (33 Act) Size: KB	Mar-31-2009	333-151495 09715763
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001209191-09-018871 ( Act) Size: 0 KB	Mar-30-2009

Recent 20 filings. View all PharmaNet Development Group Inc filings

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

PharmaNet Development Group Inc overview
PharmaNet Development Group Inc job
PharmaNet Development Group Inc stock
PharmaNet Development Group Inc ownership
PharmaNet Development Group Inc CEO
PharmaNet Development Group Inc documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.